Quarterly report [Sections 13 or 15(d)]

Commitments and Contingencies (Details Narrative)

v3.26.1
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
6 Months Ended
Apr. 27, 2026
Feb. 10, 2026
Jul. 14, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Loss Contingencies [Line Items]            
Advance in partnership restricted cash       $ 1,214   $ 741
Partnership accrued advance       483   731
Restricted cash remaining       1,214  
Contingent milestone payments       $ 178  
Loss contingency, damages sought, value $ 1,750          
License Agreement [Member]            
Loss Contingencies [Line Items]            
Contingent milestone payments       20,000    
Series A Convertible Notes [Member]            
Loss Contingencies [Line Items]            
Proceeds from other deposits   $ 1,618,000        
Restricted cash remaining       710    
STADA Arzneimittel AG [Member]            
Loss Contingencies [Line Items]            
Partnership accrued advance     $ 1,000      
Advance in partnership restricted cash       $ 504   $ 741